When the going gets tough, Bard goes shopping
This article was originally published in Clinica
Executive Summary
While CR Bard’s legal team is busy battling patients suing for injury caused by the company’s transvaginal mesh implants, the firm is focusing on growing its top-line with a new acquisition deal.